Guangdong VTR Bio-Tech Co., Ltd. (SZSE: 300381)
Health Care · Biotechnology · CN
CN¥6.29
+0.80% today · -18.7% 1Y
Guangdong VTR Bio-Tech Co., Ltd. (SZSE: 300381) operates in the Biotechnology industry within the Health Care sector. The company is valued at $449.29M and employs 1,106 people.
Over the last twelve months the share price has lost 18.7%, trading between 5.36 and 7.83.
Tweenvest scores Guangdong VTR Bio-Tech Co., Ltd. across four factors: quality 60/100, value 73/100, growth 0/100, dividend 53/100. Its strongest factor is value.
300381 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $449.29M
- Revenue (TTM)
- $122.15M
- P/E
- —
- EPS
- -0.02
- Dividend yield
- 0.79%
- Beta (5Y)
- 0.29
- 52-week high
- CN¥7.83
- 52-week low
- CN¥5.36
- Avg volume (3M)
- —
- Shares outstanding
- 480.17M
- Employees
- 1,106
- Next earnings
- —
About Guangdong VTR Bio-Tech Co., Ltd.
Guangdong VTR Bio-Tech Co., Ltd. researches, develops, produces, sells, and services bio-enzyme preparations, biosynthetics, and nutrition and health products in China and internationally. The company offers animal nutrition and health, biofuel, detergent, food and beverage, brewing, starch sweetness, bakery, plant extracts, pulp and paper, and textile enzymes, as well as biotechnology solutions. It also provides active natural products. The company also exports its products. The company was founded in 1991 and is based in Zhuhai, China.
- Founded
- 1991
- Listed since
- Jan 28, 2014
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $468.22B | $264.96 | +1.20% |
| Amgen Inc.NasdaqGS: AMGN | $237.52B | $439.33 | +1.29% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.18B | $146.12 | +1.86% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.91B | $548.05 | +1.44% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.28B | $834.04 | +0.90% |
| argenx SEENXTBR: ARGX | $65.85B | €902.00 | +1.90% |
| Moderna, Inc.NasdaqGS: MRNA | $57.92B | $145.13 | +0.04% |
| CSL LimitedASX: CSL | $57.77B | AU$168.30 | -1.69% |
Figures last refreshed Aug 18, 2026.